Life Sciences

$199.00
The Use of Statistical Process Control (SPC) Using Control Charts to Maintain Compliance in the Laboratory

 May 31 2024
 01 : 00 PM EST    
 60 Minutes
The Use of Statistical Process Control (SPC) Using Control Charts to Maintain Compliance in the Laboratory

Compliance under GLP can be difficult. The setting up of a system to monitor the performance of methods and instruments can lessen this. Statistical Process Control (SPC) uses control charts and statistical guidelines to monitor a wide variety of things in the compliant laboratory. These generate a proactive system to assess problems early on and quickly to be handled by adjustments rather than ..

$199.00
New FDA Draft Guidance Part 11 Compliance

 April 26 2024
 11 : 00 AM EST    
 90 Minutes
New FDA Draft Guidance Part 11 Compliance

This webinar describesAs part of the Case for Quality program US FDA noted how an excessive focus by the industry on compliance rather than quality may be diverting resources and management attention toward meeting regulatory compliance requirements vs. adopting best quality practices. There has also been a lower-than-anticipated investment in automation and digital technologies, which could greatly improve..

$199.00
Assays Supporting Drug Development for Cell and Gene Therapy Products

 April 30 2024
 01 : 00 PM EST    
 60 Minutes
Assays Supporting Drug Development for Cell and Gene Therapy Products

Large molecule (biologic) drugs continue to be a steadily growing component of the pharmaceutical industry. The advent of large molecule therapeutics requires a different perspective on the assays needed to support development through preclinical and clinical testing, and post market monitoring. Included in this growth are cell therapy and gene therapy products. These new therapeutic approaches have the adv..

$199.00
Complying with 21 CFR 11 for Electronic Records/Electronic Signatures

 May 03 2024
 01 : 00 PM EST    
 60 Minutes
Complying with 21 CFR 11 for Electronic Records/Electronic Signatures

21 CFR Part 11 was promulgated in 1979 to address a gaping hole in the regulations regarding the use of electronic records and electronic signatures.  The rule was, by FDA’s admission later, confusing and challenging.  Learning ObjectivesOverview of 21 CFR Part 11Explain the concepts and rationale behind the rulesDiscuss the practical application of the rule Consider challenges with the ruleWho Sh..

$199.00
Standards – Fact, Fiction or Fad?

 May 03 2024
 01 : 00 PM EST    
 60 Minutes
Standards – Fact, Fiction or Fad?

This event will help you to learn what the value of standards are including how and when to engage in the development and use of the standards.  You will hear some examples of best practices as well as Faux pas’s. You will learn about the various types of standards and what being involved brings you. You will hear about potential tools and the value of relationships and communications in the standards ..

$199.00
When does a Medical Device Start up need a Quality Management System

 May 10 2024
 01 : 00 PM EST    
 60 Minutes
When does a Medical Device Start up need a Quality Management System

As a startup developing a medical device, implementing a Quality Management System (QMS) is not just a good practice but a regulatory requirement in many jurisdictions. A QMS is crucial for ensuring that your medical device meets regulatory standards, operates safely, and delivers effective results to patients. Here's why and when you should start implementing and using a QMS:Regulatory Compliance: Regulato..

$199.00
Design History File (DHF), the Device Master Record (DMR) and the Device History Record (DHR) - Principles of Lean Documents and Lean Configuration

 May 14 2024
 01 : 00 PM EST    
 60 Minutes
Design History File (DHF), the Device Master Record (DMR) and the Device History Record (DHR) - Principles of Lean Documents and Lean Configuration

The Theory of Lean Documents is the product of applying lean principles to the creation, design, process, and management of controlled documents typically found in regulated industries. Just as lean principles challenge traditional process concepts and "push" systems, many traditional document practices are artifacts of a flawed approach. Lean documents present a fresh departure from these practices while b..

$199.00
GAMP®5, 2nd Edition and Alignment with FDA’s Draft Guidance for Computer Software Assurance (CSA)

 May 15 2024
 03 : 00 PM EST    
 90 Minutes
GAMP®5, 2nd Edition and Alignment with FDA’s Draft Guidance for Computer Software Assurance (CSA)

Gain an understanding of how newer technology should be handled when performing validation work. A different approach will be covered during the session.We will also discuss best industry practices to ensure all systems, including technology that has been around for decades, yet until recently, these were rarely used in the life science industry. (e.g., cloud, Software-as-a-Service (SaaS), Electronic Record..

$199.00
Effectively Managing CMO / CDMO

 May 21 2024
 01 : 00 PM EST    
 90 Minutes
Effectively Managing CMO / CDMO

Regulatory expectations are clear about manufacturers’ responsibility regarding supplier quality oversight. All regulatory agencies agree that pharmaceutical and medical device manufacturers are responsible for ensuring their suppliers adhere to quality standards, maintain compliance to regulatory requirements and consistently meet established expectations. Therefore, it is essential pharmaceutical and medi..

$199.00
Software development for Medical Devices under IEC 62304

 May 23 2024
 01 : 00 PM EST    
 60 Minutes
Software development for Medical Devices under IEC 62304

IEC 62304 is both a recognized consensus standard by the FDA and a harmonized standard in the EU; therefore, being compliant with the standard is the most expedient path forward for medical device products that are or contain software. IEC 62304 is also called out as a standard under the IEC 60601-1 umbrella and thus compliance to 62304 is also the best path through product safety testing (if applicable to ..

$199.00
The Identification and Auantitation of Low-Level Compounds for Impurity and Degradation Analyses

 May 28 2024
 01 : 00 PM EST    
 90 Minutes
The Identification and Auantitation of Low-Level Compounds for Impurity and Degradation Analyses

Low-level compound analysis has many differences from that of the more common analyses aimed at major components. The requirements for accuracy and precision are different. Selectivity to differentiate very similar compounds, such as isomers of the various types substituent positional, optical, and alkyl are some – becomes critical since these may differ in toxic effects. The need for definitive qualitative..

$199.00
Writing and Enforcing SOPs: Best Practices for Regulated Industries

 June 12 2024
 01 : 00 PM EST    
 90 Minutes
Writing and Enforcing SOPs: Best Practices for Regulated Industries

Writing and enforcing effective standard operating procedures (SOPs) can be challenging. Poorly written SOPs are one of the most common causes of deficiencies and observations cited in 483s and warning letters from the FDA. Companies in regulated industries must know how to organize and deliver information for the intended audience and the intended purpose. Participants will learn how to organize and delive..

$199.00
Pharma 4.0: Next Generation Technology Approach to GxP Products, Systems, Data, & FDA Compliance

 June 14 2024
 03 : 00 PM EST    
 90 Minutes
Pharma 4.0: Next Generation Technology Approach to GxP Products, Systems, Data, & FDA Compliance

Computer system validation has been regulated by FDA for more than 40 years, as it relates to systems used in the manufacturing, testing, and distribution of a product in the pharmaceutical, biotechnology, medical device or other FDA-regulated industries. The FDA requirements ensure thorough planning, implementation, integration, testing and management of computer systems used to collect, analyze and/or rep..

$199.00
Performing Virtual Internal Audits

 June 17 2024
 01 : 00 PM EST    
 60 Minutes
Performing Virtual Internal Audits

Conducting a virtual internal audit has become increasingly common in today's digital age, especially with the widespread adoption of remote work and technological advancements. While traditional audits involve physical presence and face-to-face interactions, virtual audits leverage digital tools and platforms to achieve similar objectives efficiently. Whether due to pandemic-related restrictions or the nee..

$199.00
How to Conduct a Human Factors / Usability Validation

 June 18 2024
 01 : 00 PM EST    
 60 Minutes
How to Conduct a Human Factors / Usability Validation

This webinar will explain the procedure described in ISO62366 and the 2016 FDA Guidance for compliant human factors/usability validation. HF/U validation is very different from device validation. For example, success criteria are qualitative rather than quantitative as is in device validation. Claiming success because eg. 95% of test participants did not commit a user error is not valid. Nor is 10..

Showing 1 to 15 of 224 (15 Pages)